Levetiracetam Almus

Levetiracetam, the active ingredient in Levetiracetam Almus, is a antiepileptic presented as an oral tablet for oral use. It is used to treat various seizure types in patients with epilepsy. GNH USA supplies Levetiracetam Almus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic agent that reduces abnormal neuronal firing in the brain. - Partial seizures: decreases the frequency of focal seizure episodes in patients with epilepsy. - Generalized tonic‑clonic seizures: helps control convulsive seizures that involve the whole brain. - Myoclonic seizures: reduces sudden, brief muscle jerks associated with myoclonic epilepsy.

Levetiracetam may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness: transient sensation of light‑headedness. - Fatigue: feeling unusually tired or low in energy. - Somnolence: increased sleepiness during the day. - Headache: mild to moderate head pain. - Irritability: mood changes or increased agitation. - Nausea: upset stomach or urge to vomit.

Serious or Rare Side Effects: - Severe skin reactions: such as Stevens‑Johnson syndrome. - Depression or suicidal thoughts: new or worsening mood disorders. - Blood dyscrasias: rare cases of anemia or leukopenia. - Respiratory depression: difficulty breathing, especially with other CNS depressants. - Multi‑organ hypersensitivity: systemic allergic response. - Hepatic injury: rare liver function abnormalities.

Before initiating therapy, consider the following safety measures. - Renal impairment: adjust dose based on renal function. - Hepatic dysfunction: monitor liver enzymes regularly. - Psychiatric history: observe for mood changes or depression. - Concomitant CNS depressants: use caution to avoid excessive sedation. - Pregnancy: risk category unknown; discuss potential benefits and risks with a healthcare professional. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Levetiracetam can interact with several medicines, requiring attention to dosage and monitoring.

Major Interactions (Avoid): - Carbamazepine: may lower levetiracetam plasma concentrations. - Phenobarbital: can reduce levetiracetam effectiveness. - Phenytoin: may decrease levetiracetam levels.

Moderate Interactions (Monitor Closely): - Alcohol: additive CNS depression may increase sedation. - Other antiepileptics: may require dose adjustments for optimal seizure control. - Renal excretion inhibitors: monitor renal function and consider dose modification.